ArticleInternational journal of pharmaceutics: X2026

Improving the bioavailability of nintedanib by formulating inhalable ufasomes as a targeted therapy for non-small cell lung cancer.

Salman M Ghazwani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.